Moreover, a proinflammatory milieu, hyperglycemia and hyperinsulinemia that characterize MS, lead to further increase in secretion of OPG by endothelial cells, and therefore, OPG has been proposed as a potential biomarker of MS [37]. The gene discussed is TNFRSF11B; the disease is Hyperinsulinemia.